Skip to content

Author

Hideki Maeda

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination

Risk management plans (RMPs) support lifecycle management of drug-related risks. In Japan, however, their use in clinical practice remains limited, and healthcare professionals often rely on the package insert for safety information. After RMP termination at re-examination, healthcare professionals may no longer readil...

Natsuko Kameyama, Ayana Ide, Hideki Maeda · 0 citations
Open access Sep 2026

Approval lag and loss for biologic-device combination products in Japan and the United States

Introduction The market for drug delivery devices (DDDs), including combination products that integrate pharmaceuticals and medical devices, has expanded rapidly with the increasing use of biopharmaceuticals and growing adoption of self-administration. However, the extent and causes of approval lag and approval loss fo...

Maki Mochizuki, Hideki Maeda · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.